首页> 美国卫生研究院文献>Gastroenterology Research and Practice >Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?
【2h】

Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?

机译:新辅助放化疗后延长低直肠癌手术的等待时间是否会增加围手术期并发症?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Traditionally, rectal cancer surgery is recommended 6 to 8 weeks after completing neoadjuvant chemoradiation. Extending the waiting time may increase the tumor response rate. However, the perioperative complication rate may increase. The purpose of this study was to determine the association between extending the waiting time of surgery after neoadjuvant chemoradiation and perioperative outcomes. Methods. Sixty patients with locally advanced rectal cancer who underwent neoadjuvant chemoradiation followed by radical resection at Siriraj hospital between June 2012 and January 2015 were retrospectively analyzed. Demographic data and perioperative outcomes were compared between the two groups. Results. The two groups were comparable in term of demographic parameters. The mean time interval from neoadjuvant chemoradiation to surgery was 6.4 weeks in Group A and 11.7 weeks in Group B. The perioperative outcomes were not significantly different between Groups A and B. Pathologic examination showed a significantly higher rate of circumferential margin positivity in Group A than in Group B (30% versus 9.3%, resp.; P = 0.04). Conclusions. Extending the waiting to >8 weeks from neoadjuvant chemoradiation to surgery did not increase perioperative complications, whereas the rate of circumferential margin positivity decreased.
机译:背景。传统上,建议在完成新辅助放化疗后6至8周进行直肠癌手术。延长等待时间可能会增加肿瘤反应率。但是,围手术期并发症发生率可能会增加。本研究的目的是确定新辅助放化疗后延长手术等待时间与围手术期结局之间的关系。方法。回顾性分析了2012年6月至2015年1月间在Siriraj医院接受新辅助放化疗并进行根治性切除术的60例局部晚期直肠癌患者。比较两组的人口统计学数据和围手术期结局。结果。两组在人口统计学参数方面具有可比性。 A组从新辅助化学放疗到手术的平均时间间隔为6.4周,B组为11.7周。围手术期结局在A组和B组之间无显着差异。病理检查显示,A组的周缘阳性率明显高于A组。 B组(分别为30%和9.3%; P = 0.04)。结论。将等待时间从新辅助放化疗延长到超过8周,并没有增加围手术期并发症,而周缘阳性率却下降了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号